The treatment of malignant pleural mesothelioma is still no effective method to tackle. Treatment methods, there are palliative treatment, surgical treatment, chemotherapy and radiation therapy is generally believed that the relatively limited for cancer patients in Phase I, advocated doing radical resection of the lung pleura. For Ⅱ, Ⅲ, Ⅳ stage patients, radical surgery has no meaning, only the implementation of palliative surgery. In fact, the majority of patients to disease diagnosis, has been in Phase II or above. Rapid growth in patients with pleural effusion often leads to severe respiratory difficulties, so palliative surgery for improving the quality of life of these terminally ill patients is significant. Previously used intrapleural chemotherapy drugs such as fade or promote pleural adhesion pleural effusion latch means is often difficult to be effective.
With thoracoscopic pleurodesis in malignant pleural mesothelioma, palliative treatment achieved good results, assisted thoracic surgery can completely clean the pleural fluid aspiration, and the full separation of adhesions, so that lung recruitment, and then injected into sterile talc powder, for pleurodesis to control the production of pleural fluid to alleviate clinical symptoms in patients with advanced cancer.
This excerpt from: http://cdkge.com/